- Home
- QLGN
as 11-15-2024 4:00pm EST
Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.
| Founded: | 1996 | Country: | United States |
| Employees: | 4 | City: | CALIFORNIA |
| Market Cap: | 2.7M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 226.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -41.07 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.55 - $39.15 | Next Earning Date: | 11-29-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Qualigen Therapeutics Inc. News
QLGN Breaking Stock News: Dive into QLGN Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
Shares Expected to Begin Trading on Split-Adjusted Basis on November 5, 2024
GlobeNewswire
2 months ago
Qualigen Therapeutics, Inc. Announces management changes.
GlobeNewswire
2 months ago
Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
GlobeNewswire
2 months ago
Univest Securities, LLC Announces Closing of $3.46 Million Registered Direct Offering for its Client Qualigen Therapeutics, Inc. (NASDAQ: QLGN)
GlobeNewswire
2 months ago
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
MT Newswires
2 months ago
Qualigen Therapeutics Shares Fall After $3.46 Million Public Offering Priced
GlobeNewswire
2 months ago
Qualigen Therapeutics, Inc. Announces Pricing of $3.46 Million Public Offering
GlobeNewswire
5 months ago
Lifecore Biomedical Announces Cooperation Agreement with 22NW
Compare QLGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "QLGN Qualigen Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.